The "MEGF10 Gene Myopathy Areflexia Respiratory Distress and Dysphagia Early-Onset Genetic Test" is a specialized diagnostic procedure available at DNA Labs UAE, designed to detect mutations in the MEGF10 gene, which are associated with a rare genetic disorder. This condition is characterized by a range of symptoms including muscle weakness (myopathy), absence of reflexes (areflexia), difficulty breathing (respiratory distress), and problems with swallowing (dysphagia) that manifest early in life. The test, priced at 4400 AED, involves analyzing the patient's DNA to identify any genetic alterations in the MEGF10 gene that could lead to the disorder. By providing a precise genetic diagnosis, this test enables targeted management and treatment strategies, offering hope and support to affected individuals and their families. DNA Labs UAE employs state-of-the-art technology and expertise to ensure accurate and reliable test results.
The COL6A6 gene myopathy refers to a group of disorders caused by mutations in the COL6A6 gene. This gene is crucial for encoding a component of type VI collagen, which plays a significant role in the structure and function of muscle tissue and other connective tissues. Mutations in the COL6A6 gene can lead to muscle weakness, joint abnormalities, and a variety of other symptoms, depending on the severity and type of mutation.
To diagnose conditions related to the COL6A6 gene, genetic testing is available. One such test is offered by DNA Labs UAE, a leading facility in genetic diagnostics. The COL6A6 related genetic test is a comprehensive analysis designed to detect mutations in the COL6A6 gene that could lead to myopathy and related disorders. This test is critical for confirming a diagnosis, understanding the risk of passing the mutation to offspring, and guiding treatment options.
The cost of the COL6A6 related genetic test at DNA Labs UAE is 4400 AED. This investment covers the collection of a DNA sample, usually through a blood draw or a cheek swab, and its subsequent analysis in the laboratory. The test results can provide invaluable information for affected individuals and their families, including the potential for personalized treatment plans and management strategies to improve quality of life.
The CRYAB gene myopathy, also known as desmin-related myopathy, is a rare genetic disorder characterized by muscle weakness and abnormalities. This condition is associated with mutations in the CRYAB gene, which plays a crucial role in the stability and function of muscle cells. The CRYAB gene encodes for alpha-crystallin B, a small heat shock protein that is significant in preventing the aggregation of misfolded proteins, thus ensuring the proper functioning of muscle fibers.
To diagnose this condition, a genetic test can be performed to identify mutations in the CRYAB gene. DNA Labs UAE offers this specialized test, providing a crucial tool for the accurate diagnosis of CRYAB gene myopathy. The test involves analyzing the patient's DNA to look for specific mutations in the CRYAB gene that are known to cause the disorder. This genetic test is pivotal for families with a history of the condition, as it can help in early diagnosis, management, and understanding the risk of passing the mutation to future generations.
The cost of the genetic test for CRYAB gene myopathy at DNA Labs UAE is 4400 AED. This investment is crucial for affected individuals and their families, as it provides essential information for the management of the condition, potential treatment options, and genetic counseling. Early diagnosis through this genetic test can significantly impact the quality of life of individuals with CRYAB gene myopathy by enabling timely interventions and personalized care plans.
The MYH7 gene myopathy distal type 1 genetic test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the MYH7 gene that are associated with distal myopathy type 1, a rare inherited muscle disorder. This condition is characterized by weakness and atrophy of the distal muscles, primarily affecting the lower legs and hands, and can lead to significant impairment in mobility and hand function.
Distal myopathy type 1 is caused by mutations in the MYH7 gene, which encodes the beta-myosin heavy chain protein, a crucial component of the contractile system in skeletal and cardiac muscles. The genetic test involves analyzing the patient's DNA, extracted from a blood sample, to search for specific mutations in the MYH7 gene that are known to cause the disorder.
The test is priced at 4400 AED and is conducted in the state-of-the-art facilities of DNA Labs UAE, ensuring high accuracy and reliability of the results. The test is critical for individuals with a family history of distal myopathy type 1 or those exhibiting symptoms, as a positive result can confirm the diagnosis and facilitate early intervention and management strategies. Additionally, the test can provide valuable information for family planning and genetic counseling for affected individuals and their families.
The FLNC Gene Myopathy Distal Type 4 Genetic Test is a specialized diagnostic tool designed to identify mutations in the FLNC gene, which are associated with Distal Myopathy Type 4. This condition is a rare genetic disorder characterized by muscle weakness and atrophy, primarily affecting the lower limbs and, in some cases, progressing to involve upper limbs and other muscle groups. The FLNC gene plays a crucial role in muscle function and stability, and mutations in this gene can disrupt normal muscle architecture, leading to the symptoms observed in affected individuals.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, this test involves analyzing the patient's DNA to detect abnormalities in the FLNC gene that could indicate the presence of Distal Myopathy Type 4. The process is meticulous, ensuring high accuracy and reliability in the results.
The cost of the FLNC Gene Myopathy Distal Type 4 Genetic Test is set at 4400 AED. While the price may seem significant, it reflects the advanced technology and expertise required to perform such specialized genetic testing. For patients and families affected by this condition, the test offers invaluable information for confirming the diagnosis, understanding the risk of passing the condition to offspring, and making informed decisions about management and treatment options.
DNA Labs UAE is known for its commitment to providing comprehensive and confidential genetic testing services, making it a trusted choice for individuals seeking answers to complex genetic questions.
The "DYSF Gene Myopathy Distal with Anterior Tibial Onset Genetic Test" is a specialized diagnostic assessment designed to identify mutations in the DYSF gene, which are implicated in a rare form of muscular dystrophy known as Dysferlinopathy. This condition is characterized by muscle weakness and atrophy, initially affecting the anterior tibial muscles in the legs, and can progressively involve other muscle groups. The test is crucial for confirming the diagnosis, understanding the disease progression, and guiding treatment options.
Performed at DNA Labs UAE, the test involves analyzing the patient's DNA to detect specific genetic alterations in the DYSF gene. The process requires a sample of the patient's blood or saliva, from which DNA is extracted and examined for the presence of mutations associated with the condition.
The cost of the test is set at 4400 AED, reflecting the comprehensive nature of the genetic analysis and the specialized expertise required to interpret the results. By providing a definitive diagnosis, this test plays a vital role in the management of patients with symptoms suggestive of Dysferlinopathy, enabling targeted interventions and genetic counseling for affected individuals and their families.
The CAV3 Gene Myopathy Distal Tateyama Type Genetic Test is a specialized diagnostic assessment offered by DNA Labs UAE, designed to identify mutations in the CAV3 gene, which are linked to the development of Distal Tateyama Type Myopathy. This condition is a rare form of muscle disorder that affects the distal muscles, leading to weakness and atrophy primarily in the limbs. The CAV3 gene plays a crucial role in encoding caveolin-3, a protein vital for the normal functioning of muscle cells.
The test is conducted through a detailed analysis of the patient's DNA to pinpoint any genetic abnormalities present in the CAV3 gene. It is a critical tool for confirming the diagnosis of Distal Tateyama Type Myopathy, allowing for a better understanding of the condition and enabling personalized treatment plans. The genetic test is priced at 4400 AED and is available at DNA Labs UAE, a leading facility renowned for its advanced genetic testing services and commitment to providing accurate and comprehensive diagnostic solutions.
The "TTN Gene Myopathy Early-Onset with Fatal Cardiomyopathy Genetic Test" is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the TTN gene. These mutations are associated with early-onset myopathy, a condition characterized by muscle weakness and wasting, which can lead to severe, often fatal, cardiomyopathy - a disease of the heart muscle that makes it harder for the heart to pump blood to the rest of the body.
This genetic test is crucial for individuals who exhibit symptoms of myopathy or have a family history of cardiomyopathy, as early detection can significantly influence management and treatment options. The test involves analyzing the patient's DNA to look for specific genetic alterations in the TTN gene, which is known to play a vital role in muscle function and structure.
Priced at 4400 AED, the test is conducted in the state-of-the-art facilities of DNA Labs UAE, ensuring accuracy and reliability of the results. By opting for this test, patients and their families can gain valuable insights into their genetic predisposition to these conditions, enabling them to make informed decisions regarding their health and future.
The "YARS2 Gene Myopathy Lactic Acidosis and Sideroblastic Anemia Type 2 Genetic Test" is a specialized diagnostic assessment offered by DNA Labs UAE, designed to detect mutations in the YARS2 gene. These mutations are responsible for a rare but severe condition that combines features of myopathy, lactic acidosis, and sideroblastic anemia. Myopathy affects muscle fibers, lactic acidosis involves an excess of lactic acid in the body, and sideroblastic anemia is a disorder where the bone marrow produces ringed sideroblasts rather than healthy red blood cells. The accurate identification of mutations in the YARS2 gene through this test is crucial for the diagnosis, management, and understanding of the patient's condition. The test is priced at 4400 AED, reflecting the sophisticated technology and expertise required to perform this genetic analysis. Conducted at DNA Labs UAE, this test represents an important tool in the diagnosis and treatment planning for patients affected by these complex, interconnected conditions.
The "MTAP Gene Myopathy Limb Girdle with Bone Fragility Genetic Test" is a specialized diagnostic tool available at DNA Labs UAE, designed to detect mutations in the MTAP gene. Mutations in this gene are associated with a rare genetic disorder that combines the symptoms of limb-girdle muscular dystrophy and bone fragility. This condition is characterized by progressive muscle weakness and wasting, primarily affecting the shoulder and pelvic girdles, alongside an increased susceptibility to fractures due to fragile bones.
The test is crucial for individuals showing symptoms of the disorder or those with a family history of similar conditions, as it can provide definitive genetic evidence of the disease. Early and accurate diagnosis through this test enables tailored treatment plans and management strategies to improve quality of life and mitigate the progression of symptoms.
Performed at DNA Labs UAE, a leading genetic testing facility known for its advanced diagnostic technologies and expert staff, the test costs 4400 AED. The price reflects the comprehensive analysis involved in identifying the specific genetic mutation responsible for the condition, ensuring patients and their families receive the most accurate diagnosis possible.
